MyAverix Finance
F · Healthcare
ELICERA THERAPEUTICS AB (8E8)
Biotechnology
ELICERA THERAPEUTICS AB (8E8) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8E8
ELICERA THERAPEUTICS AB (8E8) — FAQ
What is 8E8's P/E ratio?
The price-to-earnings (P/E) ratio for ELICERA THERAPEUTICS AB (8E8) is 25.00 (data as of 2026-05-23).
Does ELICERA THERAPEUTICS AB pay a dividend?
Dividend yield is not available in the current snapshot for ELICERA THERAPEUTICS AB (8E8). Check the MyAverix Finance app for the latest dividend data.
What sector is ELICERA THERAPEUTICS AB in?
ELICERA THERAPEUTICS AB (8E8) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 8E8 listed on?
8E8 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.